Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Hartigan

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Clinical Epidemiology|December 11, 1997
Predicting outcomes in HIV-infected veterans: II. Survival after AIDSL Rabeneck, P M Hartigan, I W Huang, et al.
Journal of Clinical Epidemiology|December 11, 1997
Predicting outcomes in HIV-infected veterans: I. Progression to AIDSL Rabeneck, P M Hartigan, I W Huang, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|July 13, 2000
Clinical and socioeconomic determinants of health care use among HIV-infected patients in the Department of Veterans AffairsT J Menke, L Rabeneck, P M Hartigan, et al.
Anesthesiology|November 1, 1990
Chloroprocaine antagonism of epidural opioid analgesia: a receptor-specific phenomenon?W R Camann, P M Hartigan, L I Gilbertson, et al.
Journal of Cardiothoracic and Vascular Anesthesia|December 1, 1995
Nitric oxide: delivery, measurement, and clinical applicationS C Body, P M Hartigan, S K Shernan, et al.
Annals of Internal Medicine|June 15, 1997
Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDSW A O'Brien, P M Hartigan, E S Daar, et al.
The Journal of Infectious Diseases|April 1, 1994
Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study GroupF M Gordin, P M Hartigan, N G Klimas, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1993
Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. The VA Cooperative Study GroupM H St Clair, P M Hartigan, J C Andrews, et al.
The New England Journal of Medicine|February 15, 1996
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDSW A O'Brien, P M Hartigan, D Martin, et al.
Controlled Clinical Trials|February 1, 1993
Ethical dilemmas in continuing a zidovudine trial after early termination of similar trialsM S Simberkoff, P M Hartigan, J D Hamilton, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Clinical Epidemiology|December 11, 1997
Predicting outcomes in HIV-infected veterans: II. Survival after AIDSL Rabeneck, P M Hartigan, I W Huang, et al.
Journal of Clinical Epidemiology|December 11, 1997
Predicting outcomes in HIV-infected veterans: I. Progression to AIDSL Rabeneck, P M Hartigan, I W Huang, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|July 13, 2000
Clinical and socioeconomic determinants of health care use among HIV-infected patients in the Department of Veterans AffairsT J Menke, L Rabeneck, P M Hartigan, et al.
Anesthesiology|November 1, 1990
Chloroprocaine antagonism of epidural opioid analgesia: a receptor-specific phenomenon?W R Camann, P M Hartigan, L I Gilbertson, et al.
Journal of Cardiothoracic and Vascular Anesthesia|December 1, 1995
Nitric oxide: delivery, measurement, and clinical applicationS C Body, P M Hartigan, S K Shernan, et al.
Annals of Internal Medicine|June 15, 1997
Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDSW A O'Brien, P M Hartigan, E S Daar, et al.
The Journal of Infectious Diseases|April 1, 1994
Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study GroupF M Gordin, P M Hartigan, N G Klimas, et al.
Journal of Acquired Immune Deficiency Syndromes|August 1, 1993
Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. The VA Cooperative Study GroupM H St Clair, P M Hartigan, J C Andrews, et al.
The New England Journal of Medicine|February 15, 1996
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDSW A O'Brien, P M Hartigan, D Martin, et al.
Controlled Clinical Trials|February 1, 1993
Ethical dilemmas in continuing a zidovudine trial after early termination of similar trialsM S Simberkoff, P M Hartigan, J D Hamilton, et al.
Pageof 4